12:00 AM
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Deals

Illumina, Roche deal

Roche plans to nominate up to 11 directors for election to the board of Illumina at the sequencing company's annual meeting this year as part of an unsolicited bid launched in January to acquire the biotech. The pharma also will propose increasing the size of Illumina's board to 11 from nine members. The terms of four of Illumina's directors are set to expire this year. Last year's annual meeting occurred on May 10. Delaware law requires that Illumina hold its next annual meeting within 13 months. A specific date has yet to be scheduled.


Read the full 460 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >